-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Armata Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
- Armata Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.34M, a 411% increase year-over-year.
- Armata Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.69M, a 39.3% decline year-over-year.
- Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $938K, a 69.8% decline from 2022.
- Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.11M, a 7.74% increase from 2021.
- Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.88M, a 17.1% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)